Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| 1 |
iShares MSCI ACWI ETF
ACWI
|
+$865M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$842M |
| 3 |
Direxion Daily 20+ Year Treasury Bull 3X Shares
TMF
|
+$787M |
| 4 |
iShares MSCI India ETF
INDA
|
+$760M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$725M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.17B |
| 3 |
Microsoft
MSFT
|
+$2.16B |
| 4 |
Amazon
AMZN
|
+$1.17B |
| 5 |
Netflix
NFLX
|
+$865M |
Sector Composition
| 1 | Technology | 14.92% |
| 2 | Consumer Discretionary | 7.06% |
| 3 | Financials | 6.33% |
| 4 | Healthcare | 4.61% |
| 5 | Industrials | 4.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
5026
First Commonwealth Financial
FCF
$1.84B
| $157K | ﹤0.01% |
11,295
-42,616
| -79% | -$593K |
|
|
BDN
5027
Brandywine Realty Trust
BDN
$789M
| $157K | ﹤0.01% |
32,659
-204,177
| -86% | -$980K |
|
5028
Select Water Solutions
WTTR
$946M
| $157K | ﹤0.01% |
16,965
-78,723
| -82% | -$727K |
|
5029
PLAYSTUDIOS Inc
MYPS
$121M
| $156K | ﹤0.01% |
56,223
+14,474
| +35% | +$40.2K |
|
5030
Monte Rosa Therapeutics
GLUE
$297M
| $156K | ﹤0.01% |
22,163
-48,552
| -69% | -$342K |
|
5031
Lineage Cell Therapeutics
LCTX
$306M
| $155K | ﹤0.01% |
104,800
-59,211
| -36% | -$87.6K |
|
5032
Funko
FNKO
$182M
| $155K | ﹤0.01% |
24,772
-21,025
| -46% | -$131K |
|
|
LUNA
5033
DELISTED
Luna Innovations Incorporated
LUNA
| $154K | ﹤0.01% |
48,164
+16,355
| +51% | +$52.4K |
|
5034
Global Net Lease
GNL
$1.81B
| $153K | ﹤0.01% |
19,745
-76,154
| -79% | -$592K |
|
5035
Hope Bancorp
HOPE
$1.4B
| $152K | ﹤0.01% |
13,235
-80,548
| -86% | -$927K |
|
5036
YieldMax Innovation Option Income Strategy ETF
OARK
$89.5M
| $152K | ﹤0.01% |
11,356
-1,745
| -13% | -$23.3K |
|
5037
Crexendo
CXDO
$204M
| $152K | ﹤0.01% |
31,560
-9,093
| -22% | -$43.7K |
|
5038
DiamondRock Hospitality
DRH
$1.71B
| $152K | ﹤0.01% |
15,796
-98,344
| -86% | -$945K |
|
5039
Ultrapar
UGP
$4.1B
| $151K | ﹤0.01% |
26,453
-299,453
| -92% | -$1.71M |
|
|
ELME
5040
Elme Communities
ELME
$1.51B
| $151K | ﹤0.01% |
10,819
-42,469
| -80% | -$591K |
|
5041
American Well
AMWL
$107M
| $151K | ﹤0.01% |
9,283
-28,203
| -75% | -$457K |
|
5042
ProKidney
PROK
$335M
| $150K | ﹤0.01% |
91,676
+28,848
| +46% | +$47.3K |
|
5043
Sabre
SABR
$738M
| $150K | ﹤0.01% |
61,932
-211,106
| -77% | -$511K |
|
5044
Axogen
AXGN
$755M
| $148K | ﹤0.01% |
18,389
-57,245
| -76% | -$462K |
|
|
VINC
5045
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $148K | ﹤0.01% |
+1,466
| New | +$148K |
|
5046
Lightwave Logic
LWLG
$417M
| $148K | ﹤0.01% |
31,554
-126,252
| -80% | -$591K |
|
5047
Townsquare Media
TSQ
$115M
| $147K | ﹤0.01% |
+13,432
| New | +$147K |
|
5048
SelectQuote
SLQT
$361M
| $147K | ﹤0.01% |
73,724
-19,938
| -21% | -$39.9K |
|
5049
Eos Energy Enterprises
EOSE
$2.29B
| $147K | ﹤0.01% |
143,094
-132,985
| -48% | -$137K |
|
5050
Titan International
TWI
$552M
| $147K | ﹤0.01% |
11,768
-42,408
| -78% | -$528K |
|